Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

3,703 questions · 3,824 findings · 858 reviews

No studies found 573 · 15%GRADE not reported 383 · 10%Very low 993 · 26%Low 1,062 · 27.8%Moderate 614 · 16.1%High 199 · 5.2%

Dornase alfa vs alternate days

Mean relative percentage in quality of life score at 3 months · children with cystic fibrosis

Dornase alfa daily showed no clear difference in mean relative percentage in quality of life score at 3 months compared with alternate days (low certainty).

1 finding from 1 review

Dornase alfa vs alternate days

FEV1 · children with cystic fibrosis

Dornase alfa daily showed no clear difference in mean relative percentage change in FEV1 (L) at 3 months compared with alternate days (low certainty).

1 finding from 1 review

Dornase alfa vs alternate days

Mean relative percentage in FVC (L) at 3 months · children with cystic fibrosis

Dornase alfa daily showed no clear difference in mean relative percentage in FVC (L) at 3 months compared with alternate days (low certainty).

1 finding from 1 review

Intervention not reported

Need for surgical closure of PDA (during hospital stay) · preterm or low birth weight infants with risk of having PDA on day 3 to 4 of life

The intervention probably leads to lower need for surgical closure of PDA (during hospital stay) (moderate certainty).

1 finding from 1 review

Thermotherapy one session (at 50 ºC for 30 seconds) vs meglumine antimoniate (20 mg Sb5/kg/day

Complete cure, at least 3 months after the end of treatment · People with American cutaneous leishmaniasis

Thermotherapy one session (at 50 ºC for 30 seconds) leads to lower complete cure, at least 3 months after the end of treatment compared with meglumine antimoniate (20 mg Sb5/kg/day (high certainty).

1 finding from 1 review